Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001511754 | SCV001719050 | benign | MHC class II deficiency | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001511754 | SCV001781373 | uncertain significance | MHC class II deficiency | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002568017 | SCV003703708 | uncertain significance | Inborn genetic diseases | 2021-08-13 | criteria provided, single submitter | clinical testing | The c.2384G>A (p.R795Q) alteration is located in exon 11 (coding exon 11) of the CIITA gene. This alteration results from a G to A substitution at nucleotide position 2384, causing the arginine (R) at amino acid position 795 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001511754 | SCV002093739 | likely benign | MHC class II deficiency | 2020-10-20 | no assertion criteria provided | clinical testing |